The route determines the first barrier a delivery system meets. Matching carrier architecture to route — rather than forcing a preferred formulation onto every indication — removes most early attrition.
How we work on it
Every programme in this area follows the same staged path: target definition, carrier or formulation engineering, validation in physiologically relevant models, then transfer to continuous-flow GMP production. Read the full technology overview or talk to the team.